22965-79-3 Usage
Description
Methyl 7-Chloro-7-deoxy-1-thiolincosaMinide is an organic compound that serves as an intermediate in the synthesis of lincomycin-derived antibiotics. It is a white solid with specific chemical properties that make it a crucial component in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
Methyl 7-Chloro-7-deoxy-1-thiolincosaMinide is used as an intermediate for the preparation of lincomycin-derived antibiotics. Its role in the synthesis process is essential for creating effective antibiotics that can be used to treat various bacterial infections. The compound's chemical properties contribute to the overall efficacy and potency of the final antibiotic product.
Check Digit Verification of cas no
The CAS Registry Mumber 22965-79-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,9,6 and 5 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 22965-79:
(7*2)+(6*2)+(5*9)+(4*6)+(3*5)+(2*7)+(1*9)=133
133 % 10 = 3
So 22965-79-3 is a valid CAS Registry Number.
22965-79-3Relevant articles and documents
Practical Gram-Scale Synthesis of Iboxamycin, a Potent Antibiotic Candidate
Mason, Jeremy D.,Myers, Andrew G.,Pote, Aditya R.,Terwilliger, Daniel W.
supporting information, p. 11019 - 11025 (2021/08/03)
A gram-scale synthesis of iboxamycin, an antibiotic candidate bearing a fused bicyclic amino acid residue, is presented. A pivotal transformation in the route involves an intramolecular hydrosilylation-oxidation sequence to set the ring-fusion stereocenters of the bicyclic scaffold. Other notable features of the synthesis include a high-yielding, highly diastereoselective alkylation of a pseudoephenamine amide, a convergent sp3-sp2 Negishi coupling, and a one-pot transacetalization-reduction reaction to form the target compound's oxepane ring. Implementation of this synthetic strategy has provided ample quantities of iboxamycin to allow for its in vivo profiling in murine models of infection.